Acute Pancreatitis Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight | Boston Scientific Corporation, AnGes, Mitsubishi Tanabe Pharma, B. Braun Melsungen AG, Medtronic Endovascular, Ixaka Ltd (formerly Rexge

DelveInsight's "Acute Pancreatitis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Acute Pancreatitis, historical and forecasted epidemiology as well as the Acute Pancreatitis market trends in the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan.

Discover which therapies are expected to grab the Acute Pancreatitis Market Share @ Acute Pancreatitis Market Outlook- https://www.delveinsight.com/sample-request/acute-pancreatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Acute Pancreatitis Market Report
• In March 2025, Panafina Inc. a clinical trial is to test the safety and effectiveness of a single dose of RABI-767 given by endoscopic ultrasound (EUS) guided peripancreatic injection in participants with predicted severe acute pancreatitis.
• The highest total Incident Cases of Acute Pancreatitis were accounted by the US in 2023 (~288 thousand), which is expected to show a rise in the future.
• Among the European countries, Germany had the highest Incident Cases of Acute Pancreatitis with ~53 thousand cases, followed by the UK, which had diagnosed prevalent population of ~37 thousand in 2023. On the other hand, Italy had the lowest diagnosed prevalent population (~12 thousand cases).
• Japan had ~61 thousand total Incident Cases of Acute Pancreatitis in 2023, accounting for approximately 12% in 7MM.
• Among Etiology-specific cases of Acute Pancreatitis in Japan, 73% cases were of Non-Gallstone type followed by 27% cases were of Gallstone type.
• In 2023, in the US, the gender-specific Incident Cases of Acute Pancreatitis were highest for females (~55%), as compared to males (~45%), which is attributed to factors such as hormonal differences and physiology, lifestyle and occupational factors and others.
• According to DelveInsight estimates, in 2023 based on severity specific cases approximately 40 thousand cases were of Mild severity, followed by ~12 thousand severe cases, and ~8 thousand cases were of Moderate severity in Japan.
• The management of acute pancreatitis has several unmet needs. Improved diagnostic tools are needed for early detection and prediction of severity. Current treatments are mainly supportive, highlighting the need for targeted therapies that address the disease's underlying causes.
• The leading Acute Pancreatitis companies such as Boston Scientific Corporation, AnGes, Mitsubishi Tanabe Pharma, B. Braun Melsungen AG, Medtronic Endovascular, Ixaka Ltd (formerly Rexgenero), Mercator MedSystems, Hemostemix Inc., Caladrius Biosciences, Reven Pharmaceuticals, New Beta Innovation Limited, BioGenCell Ltd., Abbott, and many others.
• Promising Acute Pancreatitis Therapies such as CM-4620-IE, Evinacumab, SCM-AGH, and many others.

Stay ahead in the Acute Pancreatitis Therapeutics Market with DelveInsight's Strategic Report @ Acute Pancreatitis Market Outlook- https://www.delveinsight.com/sample-request/acute-pancreatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Acute Pancreatitis Epidemiology Segmentation in the 7MM
• Acute Pancreatitis Incident Cases
• Acute Pancreatitis Gender-specific Incident Cases
• Acute Pancreatitis Etiology-specific Incident Cases
• Acute Pancreatitis Severity-specific Incident Cases

Download the report to understand which factors are driving Acute Pancreatitis Epidemiology trends @ Acute Pancreatitis Prevalence- https://www.delveinsight.com/sample-request/acute-pancreatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Acute Pancreatitis Emerging Drugs
• AUXORA : CalciMedica, Inc.
AUXORA is a potent and selective small-molecule inhibitor of calcium release-activated calcium (CRAC) channels. CRAC channels are found on many cell types, including immune cells and pancreatic acinar cells, where aberrant activation of these channels is thought to play a key role in the pathobiology of acute pancreatitis. AUXORA arose from CalciMedica's internal R&D, is patent- protected, and is being developed for moderately severe and severe acute pancreatitis.

Acute Pancreatitis Market Outlook
The United States accounts for the highest Acute Pancreatitis market size amongst the 7MM, during the forecast period [2024-2034]. The management of acute pancreatitis depends on the severity of disease and the concomitant complications that may arise. The treatment approach is usually based on the extent of severity and the underlying cause of the disease. The primary goal of the treatment is to relieve the pain and reduce the inflammation associated with the Pancreas. Currently, there is no therapy that is approved by the FDA to treat Acute Pancreatitis, therefore the treatment generally focuses on relieving the symptoms of pain, inflammation and any underlying complications that arises due to it.

To learn more about Acute Pancreatitis treatment guidelines, visit @ Acute Pancreatitis Treatment Market Landscape- https://www.delveinsight.com/sample-request/acute-pancreatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Acute Pancreatitis Treatment Market
The treatment of Acute pancreatitis requires hospitalization wherein the therapeutic approach is to provide fluids intravenously in order to provide adequate nutrition, analgesics are given to relieve the pain, antibiotics are recommended only when there are any infections associated with the underlying disease, diabetic medication is also given in the cases of hyperglycemia, certain pancreatic enzymes are also recommended for the treatment. Apart from these certain procedural therapies are also advised in the case of severe disease and when the cause for the disease is gall stones (biliary). The stones are usually passed on with the medications but in the case of severe disease and non-removal of stone by the given medications endoscopy, such as ERCP procedure, Endoscopic sphincterotomy, Cholecystectomy is recommended. Cholecystectomy involves the removal of gall bladder in severe cases of biliary acute pancreatitis but is only performed when the inflammation is reduced.

Scope of the Acute Pancreatitis Market Report
• Coverage- 7MM
• Study Period- 2020-2034
• Acute Pancreatitis Companies- Boston Scientific Corporation, AnGes, Mitsubishi Tanabe Pharma, B. Braun Melsungen AG, Medtronic Endovascular, Ixaka Ltd (formerly Rexgenero), Mercator MedSystems, Hemostemix Inc., Caladrius Biosciences, Reven Pharmaceuticals, New Beta Innovation Limited, BioGenCell Ltd., Abbott, and many others.
• Acute Pancreatitis Therapies- CM-4620-IE, Evinacumab, SCM-AGH, and many others.
• Acute Pancreatitis Market Dynamics: Acute Pancreatitis Market Drivers and Barriers
• Acute Pancreatitis Market Access and Reimbursement, Unmet Needs and Future Perspectives

Learn more about the FDA-approved drugs for Acute Pancreatitis @ Drugs for Acute Pancreatitis Treatment- https://www.delveinsight.com/sample-request/acute-pancreatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1 Key Insights
2 Report Introduction
3 Acute Pancreatitis Market Overview at a Glance
4 Epidemiology and Market Methodology of Acute Pancreatitis
5 Executive Summary of Acute Pancreatitis
6 Key Events
7 Disease Background and Overview
8 Epidemiology and Patient Population
9 Acute Pancreatitis Patient Journey
10 Acute Pancreatitis Emerging Therapies
11 Acute Pancreatitis: Seven Major Market Analysis
12 KOL Views
13 SWOT Analysis
14 Acute Pancreatitis Unmet Needs
15 Reimbursement and Market Access
16 Appendix
17 Bibliography
18 Report Methodology
19 About DelveInsight

List of Top Selling Market Research Reports in 2025

Biopsy devices market- https://www.delveinsight.com/report-store/biopsy-devices-market
Diabetic wound market - https://www.delveinsight.com/report-store/diabetic-wounds-market
Joint reconstruction devices market- https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Cystic fibrosis market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Heart failure market- https://www.delveinsight.com/report-store/congestive-heart-failure-market
NK Cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Positive airway pressure device market - https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
Stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Thyroid cancer market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Urinary catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Uterine fibroids market- https://www.delveinsight.com/report-store/uterine-leiomyoma-uterine-fibroids-market
Attention deficit hyperactivity disorder adhd market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lice infestations market- https://www.delveinsight.com/report-store/lice-infestations-market
Lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/

This release was published on openPR.